Dr. Andras Koser, MD
Main Job: [email protected]
Personal: [email protected]
Specialty: Hospitalist/Hospital Medicine, General Internal Medicine/ Internal Medicine
Year of Practice: Over 21 years
Dr. Andras Koser from South Carolina’s Gaffney is an internist. He is affiliated with several hospitals in the region which includes Mary Black Health System-Spartanburg and Mary Black Health System-Gaffney. Dr. Andras Koser graduated from the Faculty of Medicine of Ukraine’s Uzhhorod National University. He has been working in this field for over 20 years. Being a linguist, he knows various languages such as Russian, Hungarian, and Ukrainian.
He has worked as a Chief Executive Officer. As a matter of fact, he also has a history of working in the health care and hospital industry. Koser is an entrepreneur skilled in Disease Management, Healthcare Consulting, Medical Healthcare Industry, Physician Relations, and Clinical Research. He has fifteen years of experience of working as a clinical-pharmaceutical research’s Principal investigator.
General internal medicine internists and physicians mainly care doctors performing physical exams and treating a wide array of common illness in men and women. One of the top 4 physicians of the US is an internist. A majority of them are certified in one of nineteen subspecialties which include infectious disease, cardiology, and medical oncology.
Education and Experience
Gardner: Webb University
Other Training, focus on Healthcare Administration
Gardner: Webb University
Other Training with a focus on Healthcare Administration, Uzhhorod National University Faculty of Medicine
Medical School: Lehigh Valley Hospital
Residency, Internal Medicine: Beregovo School
Certificate and Licensure
- Certified in Internal Medicine by the American Board of Internal Medicine
- SC State Medical License valid through 2019
- NC State Medical License valid through 2019
Honors, Awards, and Recognitions
- Certified Physician Investigator 2006
- Fellow in Hospital Medicine 2009
- Fellow 2016
It is efficacy and safety of salmeterol hydrofluoroalkane and fluticasone propionate 134a metered-dose-inhaler weighed against salmeterol Diskus/ fluticasone propionate in patients with severe obstructive pulmonary disease.
Koser, A, J., Sharma, S., Emmett, Westerman, Crater, G. D., 24 hours inspiratory and bronchodilation capacity improvements with glycopyrrolate/formoterol fumarate through COPD co-suspension delivery tech. Reisner, C., Gottschlich, G., Fakih, F, Koser, A., Delacruz, L., Krainson, J., Arora, S., Feldman, G, Pudi, K, Orevillo, C., Siddiqui, S., St Rose, E., Maes, A., Martin, U.
Leave a Reply